CLOV stock · NEPH stock

CLOV vs NEPH

Clover Health Investments Corp (CLOV) versus Nephros Inc (NEPH) — a side-by-side from cached financials, not a winner call.

Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.

Nephros Inc (NEPH) is a medical instruments & supplies company listed on US.

Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.

Latest reported NEPH revenue for 2024-12-31 was $14.2M. Net income was $74.0K. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.

CLOV currently screens at market cap $1.55B. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.

Not investment advice. Open the CLOV and NEPH stock pages for the full models.

Not investment advice.

Popular Stock Comparisons